AGENT FOR TREATING MYOCARDIAL DISEASES ASSOCIATED WITH HYPERTROPHY AND PHARMACEUTICAL COMPOSITIONS

摘要

The invention relates to a novel use of bradycardiac substances such as a Ca++ channel blocker, beta-receptor blockers or if channel blockers, the if channel blockers being preferred. Said substances are optionally used in combination with a cardioactive substance for inducing the regression of myocardial diseases associated with hypertrophy, in particular for treating idiopathic hypertrophic cardiomyopathies (HCM) in humans and domestic animals.